OBL: Cnoga Medical Ltd., 5 Tarshish Street, North Industrial Park, Caesarea 3088900, ISRAEL.
OEM: OK Biotech Co. Ltd., 91 Sec. 2, Gongdao 5th Road, Hsinchu City 30070, TAIWAN ROC.
Accuracy Assessment | Recommendation | Basis | |
BG | Medaval | None | When an evaluation is carried out using a non-standard protocol, no inference can be made on accuracy based on a standard protocol. |
Pfützner A, Strobl S, Demircik F, Redert L, Pfützner J, Pfützner AH, Lier A. Evaluation of a New Noninvasive Glucose Monitoring Device by Means of Standardized Meal Experiments. J Diabetes Sci Technol. 2018 Nov;12(6):1178-1183. Epub: 2018 Feb 16. doi: 10.1177/1932296818758769. PMID: 29451016. Available from: PMC6232728.
Ad Hoc protocol Healthy (n=14), T1DM (n=6), T2DM (n=16)
After appropriate individual calibration of the noninvasive technology, both the noninvasive and the invasive Cnoga TensorTip-Combo components tracked tissue and blood glucose values reliably, respectively. This may enable patients with diabetes to monitor their glucose levels frequently, reliably and, most of all, pain-free.
Segman YJ. Device and Method for Noninvasive Glucose Assessment. J Diabetes Sci Technol. 2018 Nov;12(6):1159-1168. Epub: 2018 Mar 24. doi: 10.1177/1932296818763457. PMID: 29575926. Available from: PMC6232732.
Measurements from the Cnoga TensorTip Combo are compared to those from the Roche Accu-Chek Performa, the Ascensia Contour, the Abbott FreeStyle and the Abbott i-STAT, though not in a formal validation.